Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial

Fig. 3

Changes of VAS and SF-36 scores during 12 months after intra-articular injection of Re-Join® and HA. a VAS score for the left knee in the Re-Join® and HA groups at baseline and 6 months and 12 months after injection. b VAS score for the right knee in the Re-Join® and HA groups at baseline and 6 months and 12 months after injection (c). SF-36 score in the Re-Join® and HA groups at baseline and 6 months and 12 months after injection. Data was shown in mean and standard deviation. Statistics were determined by t test. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512